Tuesday, June 2, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Innovations & Investing

Big Tobacco Uses the Same Strategy to Hook Kids

Nothing has changed

Jon-Patrick Allem by Jon-Patrick Allem
June 6, 2024
in Innovations & Investing
0
Big Tobacco Uses the Same Strategy to Hook Kids

Arun Sharma

Millions of current smokers became addicted when they were teens – and nicotine marketing targets adolescents today just as it did decades ago. About 37 million children ages 13 to 15 around the world use tobacco, according to a 2024 report from the World Health Organization.

In 2023, e-cigarettes were the most commonly used tobacco product in the U.S., with 7.7% of middle school and high school students reporting e-cigarette use. Cigarettes were the next most common, with 1.6% of middle- and high school students saying they had consumed them in the past month.

Research shows that most people who use tobacco start in childhood.

I am a public health researcher who studies the different ways in which corporations influence adolescent health, with current projects focused on identifying sources of exposure to tobacco marketing among adolescents and young adults.

Health harms of tobacco

Smoking is harmful to every organ in the human body and is known to cause many types of cancers and heart disease, among other problems. Nicotine, by itself, in products like e-cigarettes and oral pouches, is harmful to adolescent brain development.

The adolescent brain develops into early adulthood, especially in the prefrontal cortex. This part of the brain is involved in higher cognitive development, including functions pertaining to attention, memory and cognitive flexibility. Research has shown that nicotine exposure results in long-term functional and structural changes in the brain.

Old tactics in new US products

Decades of research have documented how tobacco companies marketed tobacco products for years to attract young customers in order to sustain and grow their businesses.

In a 2021 study, my team and I showed that exposure to e-cigarette marketing with cartoon images decreased high school students’ perceptions of harm from e-cigarettes. Research makes clear that this change in perspective can make adolescents more open to trying e-cigarettes.

In an earlier study, my team and I examined the impact of e-cigarette product placement and imagery in music videos on propensity to use e-cigarettes among young adults. We found that exposure to e-cigarette product placement in music videos increased young adults’ intentions to try e-cigarettes in the future.

Striking at an early age

While our research has largely focused on the U.S. context, several recent studies have shown how tobacco companies continue to market to children in other parts of the world.

For example, a team of researchers conducted focus groups among Chinese adolescents to understand sources of tobacco marketing exposure and what features made ads attractive. They found that adolescents reported being exposed to tobacco ad campaigns near their home and school. These young Chinese people also reported that bright colors, product packaging and price promotions featured in e-cigarette ads and other promotional materials attracted their attention.

In England, a 2022 study provided an overview of marketing claims present on the websites of popular e-cigarette brands. Most notably, the study found that U.K websites featured medicinal claims for smoking cessation, associations with youth culture and depictions of young people using e-cigarettes.

Normalizing tobacco use

The emergence of social media platforms has led tobacco companies to shift their marketing tactics from traditional channels like magazines, billboards and retail stores to online channels, capitalizing on the time that young people spend on screens.

Tobacco companies have helped normalize tobacco use online with the help of branded social media account pages and social media influencers. For example, in 2021, researchers discovered that e-cigarettes were being used and promoted by influencers on Amazon-owned Twitch, a video-sharing platform popular among adolescent gamers.

Similarly, streaming platforms normalize tobacco use. For example, in a 2022 study, my team and I analyzed Netflix original TV shows and films for e-cigarette-related content. Most notably, we documented brief representations of teenagers holding e-cigarettes in the PG-13 film “Hubie Halloween.” Our findings contradict Netflix’s no e-cigarette pledge for PG-13 content.

This suggests a need for further outside-party monitoring of e-cigarettes in Netflix programming.

Spreading awareness

Every country will have to effectively enforce and expand restrictions on cigarette and e-cigarette marketing to protect children and teenagers from messages that encourage them to try smoking and vaping. Additional efforts are needed everywhere to help discourage young people from getting hooked on tobacco.

Most parents, teachers and other authority figures are likely unaware of the extent to which young people are exposed to tobacco content online, including tobacco ads and peer-generated posts on social media that normalize tobacco use.

Campaigns focused on tobacco-related digital media literacy could create awareness about tobacco products and describe how they are being marketed in the digital environment. There are various evidence-based resources that could be built upon to help young people evaluate tobacco advertising messages, empowering digital and social media users to actively evaluate information rather than remain a passive target for the industry’s marketing.

I am certain that increased awareness could prevent young people from consuming tobacco.

Jon-Patrick Allem, Associate Professor of Social and Behavioral Sciences, Rutgers University

This article is republished from The Conversation under a Creative Commons license. Read the original article.

ShareTweet
Jon-Patrick Allem

Jon-Patrick Allem

Jon-Patrick Allem is an Associate Professor of Social and Behavioral Sciences, Rutgers University

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

An in-depth exploration of drug pricing, including key databases like NADAC, WAC, and ASP, and how they influence the pharmaceutical supply chain, policy, and patient advocacy. The episode also introduces MedPricer's innovative pricing intelligence platform, offering valuable insights for healthcare professionals, policymakers, and patients.

Chapters

00:00 Understanding Drug Pricing Dynamics
03:52 Exploring the Drug Pricing Database
10:07 Patient Advocacy and Drug Pricing
13:56 Market Intelligence in Drug Pricing
How NADAC, WAC, and ASP Shape Drug CostsDaily Remedy
YouTube Video X-Tfwy7XKEg
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

by Daily Remedy
April 19, 2026
0

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • A man wearing a suit raising a judge's gavel beside a small model hospital building on a desk in a bright office.

    When Hospitals Can Be Liable for Abusive Providers

    0 shares
    Share 0 Tweet 0
  • Observations From the Rx & Illicit Drug Summit

    0 shares
    Share 0 Tweet 0
  • Case Analysis of Dr. Ball

    1 shares
    Share 0 Tweet 0
  • Retatrutide: The Weight Loss Drug Everyone Wants—But Can’t Officially Get

    1 shares
    Share 0 Tweet 0
  • Employers Don’t Really Care About Your Mental Health

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy